NCT06858644Not yet recruiting
Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning
Source: ClinicalTrials.gov · Last updated 5 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This clinical trial aims to develop a predictive model for gastric cancer (GC) peritoneal metastasis and cachexia by integrating BUB1 gene data with radiological and pathological data using advanced deep learning techniques. The study will focus on utilizing imaging genomics (radiomics) and histopathological data to identify early biomarkers for peritoneal metastasis and cachexia in GC patients. By leveraging deep learning algorithms, the project seeks to improve the accuracy and reliability of predictions, enabling earlier intervention and personalized treatment strategies. The ultimate goal is to enhance clinical decision-making and prognosis prediction in GC patients with peritoneal metastasis and cachexia.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 27 Feb 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Qun Zhao
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06858644
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Mar 2025 to the primary completion date, 1 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with other primary cancers or serious comorbidities (e.g., severe cardiovascular disease, uncontrolled diabetes).
Other
- Pregnant or breastfeeding women. Patients with contraindications to MRI or CT imaging. Those with insufficient clinical data (e.g., missing radiopathological information) for model training.
- Patients who are unable or unwilling to comply with the study protocol, including follow-up visits and evaluations.
Who the study is looking for
- Adults aged 18-75 years diagnosed with gastric cancer (GC) at any stage. Histopathologically confirmed GC with available radiological (CT/MRI) and pathological data (biopsy samples).
- Patients with or at risk of peritoneal metastasis and/or cachexia, as determined by clinical assessment and imaging.
- Ability to provide informed consent and comply with study protocols. Willingness to undergo regular follow-up imaging and clinical evaluation for the duration of the study.
Age in the registry: 18 years to 75 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.